Etiologic types of end-stage chronic liver disease in adults: Analysis of prevalence and their temporal changes from a study on native liver explants

European Journal of Gastroenterology and Hepatology

Volumn 24, Issue 10, 2012, Pages 1199-1208

  Nayak, Nabeen C ^a   Jain, Deepali ^a   Vasdev, Nandini ^a   Gulwani, Hanni ^a   Saigal, Sanjiv ^a   Soin, Arvinder ^a  

^a SIR GANGA RAM HOSPITAL   (India)

Author keywords

end stage chronic liver disease; hepatitis B virus; hepatocellular carcinoma; liver transplant; nonalcoholic fatty liver disease

Indexed keywords

ADOLESCENT; ADULT; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC LIVER DISEASE; END STAGE LIVER DISEASE; FEMALE; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NONCIRRHOTIC PORTAL FIBROSIS; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; END STAGE LIVER DISEASE; FATTY LIVER; FEMALE; HEPATITIS B; HEPATITIS C; HUMANS; INDIA; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE;

EID: 84866331073     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835643f1     Document Type: Article

References (47)

1. Launois L, Meunier B, Foglia M, Khelif D, Spiliopoulos Y, Stasik C, et al. 200 first hepatic transplantation at the Rennes University Hospital. Chirurgie 1996; 121:207-214. (Pubitemid 26231851)
2. Island ER, Pomposelli J, Pomfret EA, Gordon FD, Lewis WD, Jenkins RL. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg 2005; 140:353-358. (Pubitemid 40489952)
3. Santoyo J, Suarez MA, Fernandez-Aguilar JL, Perez Daga JA, Sanchez-Perez B, Ramirez C, et al. True impact of the indication of cirrhosis and the MELD on the results of liver transplantation. Transplant Proc 2006; 38:2462-2464. (Pubitemid 44693674)
4. Rustgi VK. The epidemiology of hepatitis C infection in the United States. J Gastroenterol 2007; 42:513-521. (Pubitemid 47190067)
5. Ayata G, Gordon FD, Lewis WD, Pomfret E, Pomposelli JJ, Jenkins RL, et al. Cryptogenic cirrhosis: clinicopathologic findings at and after liver transplantation. Hum Pathol 2002; 33:1098-1104. (Pubitemid 35416707)
6. Bhattacharjya S, Bhattacharjya T, Quaglia A, Dhillon AP, Burroughs AK, Patch DW, et al. Liver transplantation in cirrhotic patients with small hepatocellular carcinoma: an analysis of pre-operative imaging, explant histology and prognostic histologic indicators. Dig Surg 2004; 21:152-159. (Pubitemid 38812955)
7. Libbrecht L, Bielen D, Verslype C, Vanbeckevoort D, Pirenne J, Nevens F, et al. Focal lesions in cirrhotic explant livers: pathological evaluation and accuracy of pretransplantation imaging examinations. Liver Transpl 2002; 8:749-761. (Pubitemid 35012282)
8. Malek-Hosseini SA, Mehdizadeh AR, Salahi H, Saberi-Firouzi M, Bagheri-Lankarani K, Bahador A, et al. Results of liver transplantation: analysis of 140 cases at a single center. Transplant Proc 2005; 37:3157-3158. (Pubitemid 41435648)
9. Rajasekar MR, Vijayarajakumari D, Goyal R, Sewkani AS. Adult-to-adult living donor right lobe liver transplantation: the first series in India. Transplant Proc 2003; 35:70-71. (Pubitemid 36194519)
10. Nayak NC, Dhar A, Sachdeva R, Mittal A, Seth HN, Sudarsanam D, et al. Association of human hepatocellular carcinoma and cirrhosis with hepatitis B virus surface and core antigens in the liver. Int J Cancer 1977; 20: 643-665.
11. Nayak NC. Hepatocellular carcinoma-a model of human cancer: clinico-patholological features, etiology and pathogenesis. Indian J Pathol Microbiol 2003; 46:1-16. (Pubitemid 36612763)
12. Panigrahi AK, Panda SK, Dixit RK, Rao KV, Acharya SK, Dasarathy S, et al. Magnitude of hepatitis C virus infection in India: prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997; 51: 167-174. (Pubitemid 27157796)
13. Sarin SK, Guptan RC, Banerjee K, Khandekar P. Low prevalence of hepatitis C viral infection in patients with non-alcoholic chronic liver disease in India. J Assoc Physicians India 1996; 44:243-245. (Pubitemid 126461989)
14. Tandon BN, Acharya SK, Tandon A. Epidemiology of hepatitis B virus infection in India. Gut 1996; 38 (Suppl 2):S56-S59. (Pubitemid 26167507)
15. Ratziu V, Charlotte F, Heurtier A, Gombert S, Giral P, Bruckert E, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005; 128:1898-1906. (Pubitemid 40824701)
16. Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendation on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol 1978; 31:395-414. (Pubitemid 8333033)
17. Burt AD, Linda BP, Ferrel D. MacSeween's pathology of the liver. London: Churchill Livingstone; 2006.
18. Nayak NC, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol 1969; 87:359-369.
19. Sama SK, Bhargava S, Nath NG, Talwar JR, Nayak NC, Tandon BN, et al. Noncirrhotic portal fibrosis. Am J Med 1971; 51:160-169.
20. Washington MK. Autoimmune liver disease: overlaps and outliers. Mod Pathol 2007; 20:S15-S30. (Pubitemid 46733655)
21. Nayak NC, Vasdev N, Saigal S, Soin AS. End stage nonalcoholic fatty liver disease: evaluation of pathomorphologic features and relationship to cryptogenic cirrhosis from study of explant livers in a living donor liver transplant program. Hum Pathol 2010; 41:423-430.
22. Das K, Das K, Mukherjee PS, Ghosh A, Ghosh S, Mridha AR, et al. Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease. Hepatology 2010; 51:1593-1602.
23. Vasdev N, Kakati AG, Saigal S, Nayak NC. The spectrum of histological features in non-alcoholic fatty liver disease. Natl Med J India 2007; 20:282-287. (Pubitemid 351233255)
24. Brunt EM. Nonalcoholic steatohepatitis: pathologic features and differential diagnosis. Semin Diagn Pathol 2005; 22:330-338. (Pubitemid 44118640)
25. Brunt EM. Pathology of nonalcoholic steatohepatitis. Hepatol Res 2005; 33:68-71. (Pubitemid 41799777)
26. Hubscher SG. Histological assessment of non-alcoholic fatty liver disease. Histopathology 2006; 49:450-465. (Pubitemid 44631618)
27. Sathar SA, Sarkar C, Nayak N. The changing scenario of hepatitis B and hepatitis C virus associated chronic liver disease-a histopathological analysis. Med Principles Pract 1996; 5:76-85. (Pubitemid 126528841)
28. Nayak NC, Sathar SA. Chronic hepatitis-are we zeroing in on it now? In: Wagholikar UL, Deodhar KP, editors. Recent advances in pathology. New Delhi: Jaypee Publishers; 1998. pp. 126-149.
29. Sorbi D, Boynton J, Lindor KD. The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. Am J Gastroenterol 1999; 94:1018-1022. (Pubitemid 29173621)
30. Saigal S, Nayak NC, Jain D, Kumaran V, Mohanka R, Saraf N, et al. Non-cirrhotic portal fibrosis related end stage chronic liver disease in adults: evaluation from a study on living donor liver transplant recipients. Hepatol Int 2011 [Epub ahead of print].
31. Nayak NC, Jain D, Saigal S, Soin AS. Non-cirrhotic portal fibrosis: one disease with many names? An analysis from morphological study of native liver explants livers with end stage chronic liver disease. J Clin Pathol 2011; 64:592-598.
32. Vajphei K, Pal NS, Arora SK. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease-an autopsy based study. Indian J Pathol Microbiol 2006; 49:357-361. (Pubitemid 44422277)
33. Wang BE, Ma WM, Sulaiman A, Noer S, Sumoharjo S, Sumarsidi D, et al. Demographic, clinical, and virological characteristics of hepatocellular carcinoma in Asia: survey of 414 patients from four countries. J Med Virol 2002; 67:394-400. (Pubitemid 34569080)
34. Da Villa G, Piccinino F, Scolastico C, Fusco M, Piccinino R, Sepe A. Long-term epidemiological survey of hepatitis B virus infection in a hyperendemic area (Afragola, southern Italy): results of a pilot vaccination project. Res Virol 1998; 149:263-270. (Pubitemid 29486841)
35. Sagnelli E, Stroffolini T, Mele A, Almasio P, Coppola N, Ferrigno L, et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9, 997 cases. J Med Virol 2005; 75:522-527. (Pubitemid 40293519)
36. Suh DJ, Jeong SH. Current status of hepatitis C virus infection in Korea. Intervirology 2006; 49:70-75.
37. Alter MJ. Epidemiology of hepatitis C virus infection. World J Gastroenterol 2007; 13:2436-2441. (Pubitemid 46929498)
38. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006; 45:529-538. (Pubitemid 44307383)
39. Hall PD. Pathological spectrum of alcoholic liver disease. Alcohol Alcohol Suppl 1994; 2:303-313.
40. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005; 9:37-53. (Pubitemid 40341945)
41. Dhiman RK, Chawla Y, Vasishta RK, Kakkar N, Dilawari JB, Trehan MS, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol 2002; 17:6-16. (Pubitemid 34304381)
42. Ibarrola C, Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003; 42:251-264. (Pubitemid 36356858)
43. Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005; 11:627-634. (Pubitemid 40872900)
44. Isabel Fiel M, Thung SN, Hytiroglou P, Emre S, Schiano TD. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol 2007; 31:607-614. (Pubitemid 46569046)
45. Kuper HE, Tzonou A, Kaklamani E, Hadziyannis S, Tasopoulos D, Stuver S. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study using third-generation assays. Cancer Causes Control 2000; 11:171-175. (Pubitemid 30088397)
46. Sarin SK, Thakur V, Guptan RC, Saigal S, Malhotra V, Thyagarajan SP, et al. Hepatocellular carcinoma in India: an insight into the possible etiologic associations. J Gastroenterol Hepatol 2001; 16: 666-673. (Pubitemid 34188842)
47. Yoshizawa H. Hepatocellular carcinoma associated with hepatitis C virus infection in Japan: projection to other countries in the foreseeable future. Oncology 2002; 62 (Suppl1):8-17. (Pubitemid 34702014)